missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human EGFR Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 6 publications
Brand: R&D Systems MAB1095-SP
This item is not returnable.
View return policy
Description
EGFR Monoclonal specifically detects EGFR in Human samples. It is validated for Western Blot.
Specifications
| EGFR | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 ug/mL | |
| CAA25240 | |
| EGFR | |
| Mouse myeloma cell line NS0-derived recombinant human EGFR Leu25-Ser645 Accession # CAA25240 | |
| 25 μg | |
| Primary | |
| Detects human EGFR in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse (rm) EGFR, recombinant human (rh) ErbB2, rmErbB2, rhErbB3, or rhErbB4 is observed. | |
| Human | |
| Purified |
| Western Blot | |
| 102618 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 1956 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur